Position in AVTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,366,824
-$42,756 QoQ
Shares Held
128,075
-20.6% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. AVTX ranks #199 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in AVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,366,824 | 128,075 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,409,580 | 161,392 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,810,710 | 264,907 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $126 | 10 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $48 | 10 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,883 | 360 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $74 | 10 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $94 | 10 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $124 | 10 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $848 | 39 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $400 | 44 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,271 | 10,514 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,841 | 10,823 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,570 | 12,326 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $62,620 | 12,425 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $38,505 | 11,599 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,221 | 40,450 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $54,600 | 75,315 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $262,573 | 154,457 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $160,934 | 73,825 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 CERC | — | 196,679 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 CERC | — | 1,192 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 CERC | — | 52,365 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 CERC | — | 3,299 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 CERC | — | 9,054 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 CERC | — | 2,636 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||